CB2 Insights ready to move to Phase two of study with primary care physicians tool
CB2 Insights (CSE: CBII) CEO Prad Sekar joined Steve Darling from Proactive Investors Vancouver to discuss the company moving into phase 2 of the integration of their program into the Juno platform.
Sekar tells Proactive about the results of phase 1 and what they were hearing from physicians using the system.
Sekar tells Proactive about the results of phase 1 and what they were hearing from physicians using the system.
People In This Video
No users are tagged in this video